Resources Contact Us Home
Antibodies specific for soluble amyloid beta peptide protofibrils and uses thereof

Image Number 14 for United States Patent #8106164.

The invention pertains to the development of antibodies that specifically bind amyloid beta protein (Abeta) in its protofibril conformation. The invention also comprises methods of using anti-Abeta protofibril antibodies to diagnose or treat Alzheimer's disease, Down's syndrome Lewybody dementia, vascular dementia, and other neurodegenerative disorders. Furthermore, the invention pertains to the use of anti-Abeta protofibril antibodies to screen and identify substances that will modulate protofibril activity or formation in vitro or in vivo. The invention also pertains to methods for synthesising pure Abeta protofibril antigens as well as to a method for stabilising Abeta protofibrils antigens as well as to a method for stabilising Abeta protofibrils.

  Recently Added Patents
Low offset, fast response voltage controlled current source and controlling method thereof
Method and apparatus for establishing a media clip
Drinking glass with ball embedded in base
Monitoring heap in real-time by a mobile agent to assess performance of virtual machine
Progressively discovering and integrating services
Information retrieval system, information retrieval method, and information retrieval program
Triazolylphenyl sulfonamides as serine/threonine kinase inhibitors
  Randomly Featured Patents
Adjustable neckline blouse
Method and system for optimizing snow flake queries
Trim strip
Ignition system of the condensor-discharge type for internal combustion engine
Enhanced frame utilization for CSMA/CD communication protocol
Photographic documentation systems for CRT or video imaging screens
Semiconductor light-emitting device and method for manufacturing the same
Indicator for an ejection seat firing mechanism